Author: California
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 168

Get Book Here

Book Description

Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description

Author: Publishing Lawtech
Publisher: Lawtech Publishing Company Limited
ISBN: 9781933778617
Category : Law
Languages : en
Pages :

Get Book Here

Book Description
This book consists of a compendium of statutes relating to Drug & Narcotic Laws from the following Codes: California Health & Safety Code, including the California Uniform Controlled Substances Act, Business & professions, and related penal provisions from other California Codes.

Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 40

Get Book Here

Book Description

Author: Lawtech Publishing Company, Limited
Publisher:
ISBN: 9781563250897
Category :
Languages : en
Pages :

Get Book Here

Book Description

Author: Lawtech Publishing Company, Limited
Publisher:
ISBN: 9781930466852
Category :
Languages : en
Pages :

Get Book Here

Book Description

Author: James Robert Nielsen
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 262

Get Book Here

Book Description

Author: California. Laws, statutes, etc
Publisher:
ISBN:
Category : Cosmetics
Languages : en
Pages : 58

Get Book Here

Book Description

Author: Alyssa Mooney
Publisher:
ISBN: 9780438778429
Category :
Languages : en
Pages : 81

Get Book Here

Book Description
Disparate rates of felony drug arrests and convictions across race and geography have implications for inequalities in health and social outcomes linked to criminal justice exposure. California Proposition 47 (Prop 47), passed in 2014, reduced drug possession offenses classified as felonies or wobblers (with prosecutorial discretion to file felony or misdemeanor charges) to misdemeanors. This dissertation examines three effects of Prop 47: 1) whether racial/ethnic disparities in drug arrests declined; 2) whether eliminating prosecutorial discretion for charging drug possession as a felony or misdemeanor reduced geographic disparities in felony convictions; and 3) unintended consequences with regards to drug-related hospital visits. For objective 1: using data on all drug arrests made in California from 2011-2016, we compared the immediate and one year post-policy changes in racial disparities in drug arrests between Whites, Blacks, and Latinos, controlling for secular and seasonal trends. For objective 2: after propensity score matching arrests made in the year after the implementation of Prop 47 to similar arrests in the year prior to Prop 47, we used mixed models to estimate the change in county variance in the probability of felony conviction. For objective 3: Incorporating data on all drug-related hospital visits in California from 2011-2015 with drug arrests data, we use county fixed effects models to estimate expected rates in the 10-months post-policy, and calculate the difference compared to observed rates. We use linear regression to test whether county-level changes in drug arrest rates were associated with changes in drug-related hospital visit rates. In the month following passage, absolute Black-White disparities in monthly felony drug arrests decreased from 81 to 44 per 100,000 and continued to decrease over time. The probability of a felony conviction among those arrested for Prop 47 drug offenses declined by 14 percentage points (95% CI: -0.16, -0.12), from 0.21 (95% CI: 0.19, 0.24) to 0.07 (95% CI: 0.06, 0.08). Counties with higher felony conviction probabilities pre-Prop 47 declined most, reducing cross-county variance, with no evidence of increases in felony convictions for concurrent offenses. Declines in arrests were not associated with increases in drug-related hospital visits.

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309453070
Category : Science
Languages : en
Pages : 487

Get Book Here

Book Description
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.